Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biomarin Pharmaceutical Inc (BMRN) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biomarin Pharmaceutical Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1048477.
Total stock buying since 2005: $2,433,737.
Total stock sales since 2005: $583,535,292.
Total stock option exercises since 2005: $188,288,866.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 11,732 | $809,525 | 0 | $0 |
| 2024 | 0 | $0 | 255,921 | $21,765,611 | 199,347 | $12,744,795 |
| 2023 | 0 | $0 | 291,124 | $29,165,285 | 298,974 | $20,261,651 |
| 2022 | 3,625 | $314,468 | 311,275 | $27,255,098 | 253,242 | $11,640,873 |
| 2021 | 0 | $0 | 191,799 | $15,370,940 | 178,931 | $4,916,104 |
| 2020 | 12,800 | $1,005,145 | 360,561 | $39,226,570 | 301,650 | $13,887,132 |
| 2019 | 0 | $0 | 186,014 | $16,384,008 | 131,953 | $2,232,548 |
| 2018 | 0 | $0 | 443,177 | $39,824,783 | 396,390 | $13,170,758 |
| 2017 | 0 | $0 | 308,037 | $28,193,855 | 265,930 | $7,893,265 |
| 2016 | 0 | $0 | 1,279,525 | $111,508,495 | 1,208,448 | $28,339,513 |
| 2015 | 0 | $0 | 411,289 | $48,410,265 | 295,446 | $6,663,831 |
| 2014 | 0 | $0 | 340,526 | $26,836,672 | 306,781 | $7,721,726 |
| 2013 | 0 | $0 | 742,342 | $47,391,614 | 730,412 | $15,099,577 |
| 2012 | 0 | $0 | 1,247,954 | $51,415,184 | 1,198,637 | $17,833,395 |
| 2011 | 0 | $0 | 332,106 | $9,638,946 | 335,054 | $4,369,131 |
| 2010 | 800 | $16,062 | 564,962 | $13,310,700 | 545,102 | $7,510,310 |
| 2009 | 26,500 | $306,434 | 74,572 | $1,277,220 | 83,753 | $455,350 |
| 2008 | 16,752 | $218,171 | 1,172,420 | $39,560,526 | 973,113 | $8,505,589 |
| 2007 | 17,587 | $107,335 | 576,356 | $12,583,816 | 477,563 | $3,277,058 |
| 2006 | 35,493 | $362,571 | 184,500 | $2,780,052 | 284,500 | $1,766,260 |
| 2005 | 12,000 | $103,551 | 81,142 | $826,127 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-02-21 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 3,000 | 14.39 | 43,170 |
| 2019-02-14 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 4,000 | 95.20 | 380,800 |
| 2019-02-14 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 4,000 | 14.39 | 57,560 |
| 2019-02-05 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 4,000 | 98.63 | 394,520 |
| 2019-02-05 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 4,000 | 14.39 | 57,560 |
| 2019-01-22 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 3,000 | 96.82 | 290,460 |
| 2019-01-22 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 3,000 | 14.39 | 43,170 |
| 2019-01-14 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 4,000 | 93.79 | 375,160 |
| 2019-01-14 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 4,000 | 14.39 | 57,560 |
| 2019-01-10 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 3,000 | 90.55 | 271,650 |
| 2019-01-10 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 3,000 | 14.39 | 43,170 |
| 2019-01-08 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 6,000 | 91.48 | 548,856 |
| 2019-01-08 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 6,000 | 14.39 | 86,340 |
| 2019-01-07 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 3,000 | 87.58 | 262,740 |
| 2019-01-07 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 3,000 | 14.39 | 43,170 |
| 2018-12-28 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 3,000 | 84.04 | 252,120 |
| 2018-12-28 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 3,000 | 14.39 | 43,170 |
| 2018-12-27 | Lawlis V Bryan | Sale | 2,150 | 82.53 | 177,439 |
| 2018-12-27 | Lawlis V Bryan | Option Ex | 2,150 | 14.39 | 30,938 |
| 2018-12-26 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 4,000 | 80.50 | 322,000 |
| 2018-12-26 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 4,000 | 14.39 | 57,560 |
| 2018-12-14 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 2,000 | 92.64 | 185,280 |
| 2018-12-14 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 2,000 | 17.86 | 35,720 |
| 2018-12-12 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 2,000 | 93.12 | 186,240 |
| 2018-12-12 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 2,000 | 17.86 | 35,720 |
| 2018-11-14 | Ajer Jeffrey Robert (EVP, Chief Commercial Officer) | Sale | 9,000 | 93.00 | 836,973 |
| 2018-11-14 | Ajer Jeffrey Robert (EVP, Chief Commercial Officer) | Option Ex | 9,000 | 63.10 | 567,900 |
| 2018-11-02 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 1,500 | 97.88 | 146,820 |
| 2018-11-02 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 1,500 | 17.86 | 26,790 |
| 2018-11-01 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 4,000 | 92.55 | 370,200 |
| 2018-11-01 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 4,000 | 14.39 | 57,560 |
| 2018-10-30 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 1,000 | 14.39 | 14,390 |
| 2018-10-24 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 1,000 | 14.39 | 14,390 |
| 2018-10-03 | Ajer Jeffrey Robert (EVP, Chief Commercial Officer) | Sale | 1,000 | 98.98 | 98,985 |
| 2018-10-03 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 1,500 | 99.36 | 149,040 |
| 2018-10-03 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 1,500 | 17.86 | 26,790 |
| 2018-09-27 | Lawlis V Bryan | Sale | 2,150 | 97.93 | 210,549 |
| 2018-09-27 | Lawlis V Bryan | Option Ex | 2,150 | 14.39 | 30,938 |
| 2018-09-25 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 1,000 | 14.39 | 14,390 |
| 2018-09-14 | Davis George Eric (EVP, General Counsel) | Sale | 2,216 | 99.45 | 220,390 |
| 2018-09-13 | Davis George Eric (EVP, General Counsel) | Sale | 12,000 | 99.57 | 1,194,840 |
| 2018-09-13 | Meier Richard A | Sale | 3,000 | 99.25 | 297,735 |
| 2018-09-13 | Meier Richard A | Option Ex | 15,000 | 21.51 | 322,650 |
| 2018-09-05 | Heron Elaine J | Sale | 1,000 | 96.94 | 96,935 |
| 2018-09-04 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 1,500 | 98.16 | 147,240 |
| 2018-09-04 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 1,500 | 17.86 | 26,790 |
| 2018-08-28 | Lewis Alan | Sale | 7,500 | 99.11 | 743,362 |
| 2018-08-28 | Lewis Alan | Option Ex | 7,500 | 14.39 | 107,925 |
| 2018-08-27 | Meier Richard A | Sale | 2,000 | 100.12 | 200,236 |
| 2018-08-27 | Meier Richard A | Option Ex | 15,000 | 14.39 | 215,850 |
| 2018-08-27 | Fuchs Henry J (President, Worldwide R&D) | Sale | 12,500 | 100.00 | 1,250,000 |
| 2018-08-24 | Fuchs Henry J (President, Worldwide R&D) | Sale | 12,500 | 99.00 | 1,237,500 |
| 2018-08-21 | Lewis Alan | Sale | 4,200 | 100.09 | 420,365 |
| 2018-08-07 | Baffi Robert (EVP, Technical Operations) | Sale | 5,173 | 105.00 | 543,165 |
| 2018-07-23 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 1,500 | 101.69 | 152,535 |
| 2018-07-23 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 1,500 | 17.86 | 26,790 |
| 2018-06-27 | Lawlis V Bryan | Sale | 2,150 | 93.52 | 201,068 |
| 2018-06-27 | Lawlis V Bryan | Option Ex | 2,150 | 14.39 | 30,938 |
| 2018-06-22 | Mueller Brian (SVP, Corporate Controller) | Sale | 3,145 | 99.50 | 312,927 |
| 2018-06-22 | Mueller Brian (SVP, Corporate Controller) | Option Ex | 2,491 | 28.23 | 70,320 |
| 2018-06-22 | Baffi Robert (EVP, Technical Operations) | Sale | 6,949 | 99.00 | 687,985 |
| 2018-06-22 | Baffi Robert (EVP, Technical Operations) | Option Ex | 6,949 | 14.39 | 99,996 |
| 2018-06-22 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Sale | 10,000 | 99.00 | 990,050 |
| 2018-06-15 | Mueller Brian (SVP, Corporate Controller) | Sale | 2,021 | 94.50 | 190,984 |
| 2018-06-14 | Fuchs Henry J (President, Worldwide R&D) | Sale | 31,000 | 90.00 | 2,790,031 |
| 2018-06-14 | Fuchs Henry J (President, Worldwide R&D) | Option Ex | 31,000 | 29.88 | 926,342 |
| 2018-06-13 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 1,000 | 14.39 | 14,390 |
| 2018-06-11 | Ajer Jeffrey Robert (EVP, Chief Commercial Officer) | Sale | 1,436 | 90.31 | 129,685 |
| 2018-05-17 | Meier Richard A | Option Ex | 15,000 | 38.59 | 578,850 |
| 2018-05-17 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 18,750 | 88.66 | 1,662,356 |
| 2018-05-17 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 18,750 | 38.59 | 723,562 |
| 2018-05-16 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 18,750 | 89.13 | 1,671,131 |
| 2018-05-16 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 18,750 | 38.59 | 723,562 |
| 2018-05-15 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 18,750 | 88.29 | 1,655,437 |
| 2018-05-15 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 18,750 | 38.59 | 723,562 |
| 2018-05-14 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 18,750 | 89.22 | 1,672,856 |
| 2018-05-14 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 18,750 | 38.59 | 723,562 |
| 2018-05-11 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 18,750 | 88.42 | 1,657,856 |
| 2018-05-11 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 18,750 | 38.59 | 723,562 |
| 2018-05-10 | Mueller Brian (SVP, Corporate Controller) | Sale | 2,450 | 89.50 | 219,275 |
| 2018-05-10 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 18,750 | 89.59 | 1,679,793 |
| 2018-05-10 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 18,750 | 38.59 | 723,562 |
| 2018-05-07 | Ajer Jeffrey Robert (EVP, Chief Commercial Officer) | Sale | 309 | 85.96 | 26,561 |
| 2018-04-24 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 10,000 | 82.29 | 822,890 |
| 2018-04-24 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 10,000 | 38.59 | 385,900 |
| 2018-04-23 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Sale | 11,059 | 82.15 | 908,496 |
| 2018-04-23 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 10,000 | 82.58 | 825,810 |
| 2018-04-23 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 10,000 | 38.59 | 385,900 |
| 2018-04-20 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 10,000 | 83.65 | 836,460 |
| 2018-04-20 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 10,000 | 38.59 | 385,900 |
| 2018-04-17 | Lawlis V Bryan | Sale | 3,750 | 85.00 | 318,750 |
| 2018-04-17 | Lawlis V Bryan | Option Ex | 3,750 | 38.59 | 144,712 |
| 2018-04-05 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 1,000 | 14.39 | 14,390 |
| 2018-04-02 | Ajer Jeffrey Robert (EVP, Chief Commercial Officer) | Sale | 2,119 | 80.12 | 169,774 |
| 2018-04-02 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 1,000 | 14.39 | 14,390 |
| 2018-04-02 | Fuchs Henry J (President, Worldwide R&D) | Sale | 10,000 | 80.12 | 801,200 |
| 2018-04-02 | Fuchs Henry J (President, Worldwide R&D) | Option Ex | 10,000 | 31.98 | 319,750 |
| 2018-03-29 | Ajer Jeffrey Robert (EVP, Chief Commercial Officer) | Sale | 1,537 | 79.69 | 122,483 |
| 2018-03-28 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 2,000 | 16.12 | 32,250 |
| 2018-03-27 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 1,000 | 14.39 | 14,390 |
| 2018-03-26 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 1,000 | 14.39 | 14,390 |
| 2018-03-23 | Davis George Eric (EVP, General Counsel) | Sale | 3,350 | 81.35 | 272,522 |
| 2018-03-22 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 1,000 | 14.39 | 14,390 |
| 2018-03-21 | Ajer Jeffrey Robert (EVP, Chief Commercial Officer) | Sale | 4,368 | 83.90 | 366,475 |
| 2018-03-16 | Davis George Eric (EVP, General Counsel) | Sale | 3,818 | 83.88 | 320,253 |
| 2018-03-16 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 15,000 | 83.26 | 1,248,855 |
| 2018-03-16 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 15,000 | 38.59 | 578,850 |
| 2018-03-15 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 15,000 | 84.73 | 1,270,905 |
| 2018-03-15 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 15,000 | 38.59 | 578,850 |
| 2018-03-09 | Ajer Jeffrey Robert (EVP, Chief Commercial Officer) | Sale | 2,972 | 82.39 | 244,863 |
| 2018-03-05 | Davis George Eric (EVP, General Counsel) | Sale | 2,105 | 79.04 | 166,379 |
| 2018-03-02 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 1,000 | 14.39 | 14,390 |
| 2018-02-15 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 10,000 | 84.63 | 846,290 |
| 2018-02-15 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 10,000 | 38.59 | 385,900 |
| 2018-02-01 | Davis George Eric (EVP, General Counsel) | Sale | 30,000 | 90.66 | 2,719,680 |
| 2018-02-01 | Davis George Eric (EVP, General Counsel) | Option Ex | 30,000 | 38.59 | 1,157,700 |
| 2018-01-05 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 10,000 | 90.32 | 903,199 |
| 2018-01-05 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 10,000 | 38.59 | 385,900 |
| 2018-01-02 | Lawlis V Bryan | Sale | 3,750 | 88.84 | 333,150 |
| 2018-01-02 | Lawlis V Bryan | Option Ex | 3,750 | 38.59 | 144,712 |
| 2018-01-02 | Fuchs Henry J (President, Worldwide R&D) | Sale | 15,000 | 89.23 | 1,338,405 |
| 2018-01-02 | Fuchs Henry J (President, Worldwide R&D) | Option Ex | 15,000 | 31.98 | 479,625 |
| 2017-12-29 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 10,000 | 89.61 | 896,130 |
| 2017-12-29 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 10,000 | 38.59 | 385,900 |
| 2017-12-28 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 10,000 | 89.89 | 898,910 |
| 2017-12-28 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 10,000 | 38.59 | 385,900 |
| 2017-12-14 | Heron Elaine J | Sale | 800 | 88.89 | 71,116 |
| 2017-11-30 | Davis George Eric (EVP, General Counsel) | Sale | 1,200 | 85.64 | 102,766 |
| 2017-09-28 | Baffi Robert (EVP, Technical Operations) | Sale | 18,415 | 92.28 | 1,699,299 |
| 2017-09-22 | Ajer Jeffrey Robert (EVP, Chief Commercial Officer) | Sale | 3,521 | 95.00 | 334,495 |
| 2017-09-22 | Ajer Jeffrey Robert (EVP, Chief Commercial Officer) | Option Ex | 3,521 | 37.46 | 131,896 |
| 2017-09-15 | Lawlis V Bryan | Sale | 3,750 | 91.26 | 342,225 |
| 2017-09-15 | Lawlis V Bryan | Option Ex | 3,750 | 38.59 | 144,712 |
| 2017-09-15 | Fuchs Henry J (President, Worldwide R&D) | Sale | 15,000 | 90.50 | 1,357,500 |
| 2017-09-15 | Fuchs Henry J (President, Worldwide R&D) | Option Ex | 15,000 | 31.98 | 479,625 |
| 2017-06-23 | Davis George Eric (EVP, General Counsel) | Sale | 9,844 | 96.60 | 950,930 |
| 2017-06-23 | Davis George Eric (EVP, General Counsel) | Option Ex | 9,844 | 38.59 | 379,879 |
| 2017-06-22 | Mueller Brian (SVP, Corporate Controller) | Sale | 2,671 | 100.00 | 267,100 |
| 2017-06-22 | Mueller Brian (SVP, Corporate Controller) | Option Ex | 2,671 | 21.51 | 57,453 |
| 2017-06-19 | Fuchs Henry J (President, Worldwide R&D) | Sale | 603 | 90.00 | 54,270 |
| 2017-06-19 | Fuchs Henry J (President, Worldwide R&D) | Option Ex | 603 | 37.46 | 22,588 |
| 2017-06-16 | Lawlis V Bryan | Sale | 3,750 | 90.00 | 337,500 |
| 2017-06-16 | Lawlis V Bryan | Option Ex | 3,750 | 38.59 | 144,712 |
| 2017-06-16 | Fuchs Henry J (President, Worldwide R&D) | Sale | 14,397 | 90.00 | 1,295,730 |
| 2017-06-16 | Fuchs Henry J (President, Worldwide R&D) | Option Ex | 14,397 | 31.98 | 460,344 |
| 2017-06-09 | Davis George Eric (EVP, General Counsel) | Option Ex | 9,239 | 24.00 | 221,736 |
| 2017-06-07 | Ajer Jeffrey Robert (EVP, Chief Commercial Officer) | Sale | 1,004 | 89.61 | 89,968 |
| 2017-06-05 | Davis George Eric (EVP, General Counsel) | Sale | 9,471 | 91.04 | 862,230 |
| 2017-06-05 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 5,000 | 90.56 | 452,800 |
| 2017-06-05 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 5,000 | 17.33 | 86,649 |
Insider trading activities including stock purchases, stock sales, and option exercises of BMRN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biomarin Pharmaceutical Inc (symbol BMRN, CIK number 1048477) see the Securities and Exchange Commission (SEC) website.